SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  -------------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

        Date of report (Date of earliest event reported): April 15, 2005

                           OPHTHALMIC IMAGING SYSTEMS
                           ---------------------------
             (Exact Name of Registrant as Specified in its Charter)


CALIFORNIA                                1-11140                 94-3035367
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of   (Commission File Number)     (I.R.S. Employer
Incorporation)                                               Identification No.)


          221 Lathrop Way, Suite I
           Sacramento, California                                 95815
- --------------------------------------------------------------------------------
  (Address of Principal Executive Offices)                      (Zip Code)


(Registrant's telephone number, including area code):   (916) 646-2020


                                 Not Applicable
- --------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)



Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):


|_|      Written  communications  pursuant to Rule 425 under the  Securities Act
         (17 CFR 230.425)
|_|      Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
         CFR 240.14a-12)
|_|      Pre-commencement  communications  pursuant to Rule  14d-2(b)  under the
         Exchange Act (17 CFR 240.14d-2(b))
|_|      Pre-commencement  communications  pursuant to Rule  13e-4(c)  under the
         Exchange Act (17 CFR 240.13e-4(c))




ITEM 8.01.   OTHER EVENTS.

         On April 15, 2005, the Board of Directors of the Registrant adopted the
Amended  and  Restated  Bylaws of the  Registrant,  a copy of which is  attached
hereto as exhibit 99.1.

         The Amended and Restated Bylaws restate in their entirety the Bylaws of
the Registrant (the "Original Bylaws") as originally  certified on July 21, 1986
and as amended on March 25, 1992, May 9, 1992, January 23, 1993, and January 28,
1998.

         The Amended and Restated Bylaws amend the section titled "President" as
set forth in Article III Section 7 of the Original By-laws and add a new Section
7 "Chief  Executive  Officer".  Other  conforming  changes have been made in the
Amended and Restated Bylaws.

Section 7 of the Original Bylaws provided:

         "Section 7. PRESIDENT.  Subject to such supervisory  powers,
         if any,  as may be given by the  Board of  Directors  to the
         Chairman  of the  Board,  if there be such an  Officer,  the
         president  shall  be  the  Chief  Executive  Officer  of the
         corporation  and shall,  subject to the control of the Board
         of  Directors,  have  general  supervision,   direction  and
         control of the business and Officers of the corporation.  He
         or she shall preside at all meetings of the Shareholders and
         in the absence of the Chairman of the Board,  or if there be
         none,  at  all  meetings  of the  Board  of  Directors.  The
         President  shall be ex officio a member of all the  standing
         committees,  including the Executive Committee,  if any, and
         shall  have the  general  powers  and  duties of  management
         usually  vested in the office of President of a corporation,
         and  shall  have  such  other  powers  and  duties as may be
         prescribed by the Board of Directors or the Bylaws."

New Sections 7 and 8 of the Amended and Restated Bylaws provide as follows:

         "Section  7.  CHIEF  EXECUTIVE  OFFICER.   Subject  to  such
         supervisory  powers, if any, as may be given by the Board of
         Directors to the Chairman of the Board,  if there be such an
         Officer,  the Chief  Executive  Officer  of the  corporation
         shall,  subject to the  control  of the Board of  Directors,
         have  general  supervision,  direction  and  control  of the
         business  and Officers of the  corporation.  He or she shall
         preside  at  all  meetings  of the  Shareholders  and in the
         absence of the  Chairman of the Board,  or if there be none,
         at all  meetings  of the  Board  of  Directors.  Subject  to
         applicable  laws,  the Chief  Executive  Officer shall be ex
         officio a member of all the standing  committees,  including
         the Executive Committee,  if any, and shall have the general
         powers and duties of management usually vested in the office
         of Chief Executive Officer of a corporation,  and shall have
         such other  powers and  duties as may be  prescribed  by the
         Board of Directors or the Bylaws.

         Section 8.  PRESIDENT.  The President shall have such powers
         and duties as may be prescribed by the Board of Directors or
         the Bylaws."

                                      -2-


ITEM 9.01.   FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits:

Exhibit Number    Description

99.1              Amended and Restated By-laws of the Registrant.





                              SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended,  the  registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

Date:    May 4, 2005

                                               OPHTHALMIC IMAGING SYSTEMS


                                               By: /s/ Ariel Shenhar
                                                  ------------------------
                                                  Name:  Ariel Shenhar
                                                  Title: Chief Financial Officer





                                  EXHIBIT INDEX

Exhibit
Number           Description

99.1             Amended and Restated By-laws of the Registrant.